Valeant to Divest Itself of Sprout Pharmaceuticals Unit

Valeant will sell Sprout Pharmaceuticals to former Sprout shareholders after they accused the struggling pharmaceutical giant of botching the marketing of a female libido treatment.

from WSJ.com: US Business http://ift.tt/2h81rv9
via IFTTT